Cough medicine prescriptions for children were significantly reduced by a systematic intervention that reinforced national recommendations.
Cough medicine prescriptions for children were significantly reduced by a systematic intervention that reinforced national recommendations.
复制标题
DOI:
10.1111/apa.16284
复制
发表时间:
2022-06
期刊:
影响因子:
3.8
通讯作者:
Csonka, Peter
中科院分区:
文献类型:
--
作者:
Palmu, Sauli;Heikkila, Paula;Kivisto, Juho E.;Poutanen, Roope;Korppi, Matti;Renko, Marjo;Csonka, Peter
Coughs are one of the most frequent reasons for visiting a physician during childhood. They disrupt sleep, are uncomfortable and cause anxiety for both children and their parents. It is widely accepted that cough medicines should not be prescribed, or recommended, for children. We previously published data on cough medicine prescriptions before and after the 2014 Finnish Current Care Guidelines on children's lower respiratory tract infections (LRTIs) were published. These guidelines advice not to prescribe cough medicines to children. The data were collected from three public and two private outpatient clinics. They comprised 153 prescriptions for cough medicines, issued during 1661 visits for children's LRTIs 1 in November and December 2012 and 2013 and the same months in 2014 and 2015. This showed that the guidelines had no immediate impact on cough medicine prescriptions. 1 We then designed a systematic intervention to reduce prescriptions for cough medicines, which is described in more detail below. It significantly reduced cough medicine prescriptions issued in 2017–2020 by Terveystalo, the largest private health care service company in Finland, which receives 260,000 paediatric visits per year. 2 This study built on those studies, 1, 2 by evaluating cough medicine prescriptions with LRTIs issued to children aged 0–15 years by two private outpatient clinics run by Terveystalo from 1 January 2014 to 31 December 2020. These clinics, in Tampere in South-West Finland and Kouvola in South-East Finland, also took part in the previous studies. 1, 2 This enabled us to evaluate the impact of the 2014 guidelines 1 and whether the active intervention in 2017–2020 2 provided greater momentum for eradicating cough medicine prescriptions especially for children with LRTIs.Terveystalo's electronic health record system enabled us to carry out a follow-up study based on real-time data about specific physicians. The 2017–2020 intervention aimed to eradicate cough medicine prescriptions for children, by sending educational material to physicians and caregivers. These were based on the Finnish guidelines, which do not recommend cough medicines for children. General reminders were sent to physicians who had prescribed cough medicines and they were sent personalised letters, followed up by phone calls, if they continued prescribing.
影响因子:
3.6
作者:
Csonka P;Heikkilä P;Koskela S;Palmu S;Lajunen N;Riihijärvi S;Huhtala H;Korppi M
通讯作者:
Korppi M
影响因子:
1.6
作者:
Diaz, Maria Carmen G.;Handy, Lori K.;Werk, Lloyd N.
通讯作者:
Werk, Lloyd N.